Dr. Cheng is a research assistant professor in the Lucas / McAllister Lab in the Rangos Research Center of the UPMC Children's Hospital of Pittsburgh. Currently, her primary research is focusing on identifying novel binding partners for MALT1, which is the effector molecule of the CARMA-Bcl10-MALT1 (CBM) signalosome, which plays an important role in normal lymphocyte function and lymphomagenesis.
Education & Training
- PhD-Peking University Health Science Center, Beijing, China
Dr. Cheng's research interest is mainly on studying the mechanisms by which dysregulated intracellular signaling contributes to inflammatory disease and tumorigenesis.